BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30414839)

  • 1. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
    Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
    Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
    Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
    Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpinetin inhibits lipopolysaccharide-induced acute kidney injury in mice.
    Huang Y; Zhou LS; Yan L; Ren J; Zhou DX; Li SS
    Int Immunopharmacol; 2015 Oct; 28(2):1003-8. PubMed ID: 26321118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
    Hu JJ; Wang H; Pan CW; Lin MX
    Microb Pathog; 2018 Jun; 119():86-92. PubMed ID: 29604422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
    Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
    Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
    Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Tian Y; Li Z; Shen B; Zhang Q; Feng H
    Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
    Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y
    J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panaxynol from
    Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
    Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
    Li Y; Wang N; Jiang Y
    Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis.
    Zhu Z; Hu R; Li J; Xing X; Chen J; Zhou Q; Sun J
    Int Immunopharmacol; 2021 Jul; 96():107660. PubMed ID: 33862553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis.
    He X; Wei Z; Wang J; Kou J; Liu W; Fu Y; Yang Z
    Sci Rep; 2016 Jun; 6():28370. PubMed ID: 27321991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
    Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
    Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betulin inhibits lipopolysaccharide/D-galactosamine-induced acute liver injury in mice through activating PPAR-γ.
    Xu GM; Zan T; Li HY; Han JF; Liu ZM; Huang J; Dong LH; Zhang HN
    Biomed Pharmacother; 2018 Oct; 106():941-945. PubMed ID: 30119266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
    He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
    Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpinetin attenuates inflammatory responses by interfering toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced mastitis in mice.
    Chen H; Mo X; Yu J; Huang Z
    Int Immunopharmacol; 2013 Sep; 17(1):26-32. PubMed ID: 23669335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
    Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
    Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.